John D. Halpern 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 07:05 am Purchase | 2023-12-31 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 550,894 9.990% | 98,611 (+21.80%) | Filing |
| 2023-01-31 4:05 pm Purchase | 2023-01-31 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 452,283 8.800% | 1,117 (+0.25%) | Filing |
| 2022-12-05 5:20 pm Sale | 2022-12-02 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 451,166 8.800% | -4,296,079 (-90.50%) | Filing |